查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2059312

實驗室自動化市場：市場洞察、競爭格局與市場預測（2034 年）

Lab Automation - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

實驗室自動化市場概述

  • 全球實驗室自動化市場預計將從 2025 年的 95.7112 億美元成長到 2034 年的 225.0113 億美元，展現出強勁且持續的成長勢頭。
  • 全球實驗室自動化市場預計在 2026 年至 2034 年的預測期內將以 10.07% 的年複合成長率成長。
  • 人手不足和壓力、生物製藥研發的加速以及對高通量診斷日益成長的需求，都在推動實驗室自動化技術的快速普及，因為它能夠有效應對現代實驗室在產能和效率方面的挑戰。隨著熟練的實驗室人員日益稀缺，營運成本不斷攀升，自動化有助於提高生產效率和一致性，同時減少對人工操作的依賴。同時，生物製藥研發管線的快速擴張和複雜的藥物發現過程，對更快的實驗速度、擴充性的篩檢和更高的數據準確性提出了更高的要求，而這些都可以透過自動化系統來實現。同樣，對高通量診斷檢測（尤其是在基因組學、感染疾病和個人化醫療領域）日益成長的需求，也進一步推動了對能夠快速、準確地處理大量檢體的自動化平台的需求，最終促進了整個市場的成長。
  • 在實驗室自動化市場中運作的主要公司包括 Thermo Fisher Scientific、Danaher Corporation、Siemens Healthineers、Abbott、F. Hoffmann-La Roche Ltd、Agilent Technologies、PerkinElmer (Revvity)、Tecan Group、Hamilton Company、SPT Labtech、Hudson Lab Automation、Qiagen NVMling、Labi​​株、Vans、Lab、Qiagen NVs、Giagen 7, Lab、Lab」 Inc.、Opentrons、Scispot、Clinisys、Ginkgo Bioworks 和 LabWare。
  • 北美預計將成為實驗室自動化市場的主要驅動力，這得益於該地區眾多大型製藥、生物技術和診斷公司的強大影響力，以及先進的醫療和研究基礎設施。該地區在藥物研發、臨床診斷和基因組學研究等領域，對機器人系統、人工智慧驅動的實驗室平台和數位化工作流程技術的應用日益廣泛。此外，生物製藥研發投入的增加、對高通量檢測需求的成長，以及賽默飛世爾科技、丹納赫公司和安捷倫科技等行業領導者的存在，都進一步推動了該地區的市場成長。
  • 在實驗室自動化市場產品中，預計到 2025 年，產品類型將佔據最大的市場佔有率。

推動實驗室自動化市場成長的因素

  • 勞動力短缺和勞動力壓力推動實驗室自動化蓬勃發展：熟練實驗室專業人員的短缺日益嚴重，人事費用不斷上漲，導致實驗室自動化的需求顯著成長。自動化系統有助於減輕實驗室的人工勞動負擔，提高營運效率，最大限度地減少人為錯誤，即使在人員有限的情況下也能維持穩定的生產力。
  • 加速生物製藥領域的研發：生物製藥研究和藥物發現的快速發展推動了對自動化實驗室工作流程的需求。實驗室自動化能夠實現快速檢體處理、高通量篩檢和更高的數據準確性，從而幫助製藥和生物技術公司縮短藥物發現和開發週期。
  • 高通量診斷的需求：基因組學、感染疾病和個人化醫療等領域對大規模診斷檢測的需求日益成長，推動了實驗室自動化系統的應用。自動化診斷平台能夠快速且準確地處理大量檢體，縮短檢測結果報告時間，並支援臨床檢查室的高效運作。

實驗室自動化市場報告細分

本實驗室自動化市場報告全面概​​述了全球實驗室自動化市場，重點分析了關鍵趨勢、成長要素、挑戰和機會。報告從產品、軟體、自動化類型、工作流程、應用、最終用戶和地區等維度對市場進行了分析，並深入剖析了北美、歐洲和亞太等主要市場的競爭格局、監管環境和市場動態。報告詳細介紹了主要產業參與企業的概況和近期產品創新，為企業提供關鍵數據，幫助他們識別市場潛力、制定策略規劃，並掌握快速成長的實驗室自動化市場中的新興機會。

實驗室自動化市場指的是一個由自動化硬體、專用軟體和整合機器人平台組成的綜合生態系統，旨在以最少的人工干預執行實驗室任務，從而提高臨床診斷和研究工作流程的處理能力、準確性和數據完整性。

人手不足和壓力、生物製藥研發的加速以及對高通量診斷日益成長的需求，正推動實驗室自動化市場強勁成長，幫助檢查室克服營運、效率和擴充性方面的挑戰。在許多地區，熟練的實驗室專業人員越來越難招到，因此檢查室正在加速採用自動化解決方案，以減少對人工操作的依賴，提高工作流程的一致性，最大限度地減少人為錯誤，並在人員短缺的情況下保持生產力。自動化液體處理系統、機器人檢體處理系統和人工智慧驅動的工作流程平台使實驗室能夠更快、更準確地執行重複性和複雜的任務。

同時，包括生物製藥、細胞和基因療法、疫苗以及個人化醫療在內的生物製藥研究的快速發展，推動了對更快、更有效率的研究流程的需求日益成長。製藥和生物技術公司正大力投資自動化實驗室技術，以加速藥物發現、高通量篩檢、樣本製備和數據分析。自動化不僅縮短了研發週期，還提高了實驗的可重複性，並實現了現代藥物發現所需的大規模實驗。

此外，對高通量診斷日益成長的需求進一步加速了臨床和檢查室採用實驗室自動化系統。隨著基因組學、感染疾病檢測、分子診斷和精準醫療等領域檢測量的不斷成長，檢查室需要在維持高精度和符合監管要求的前提下，快速處理數千個檢體。自動化診斷平台能夠縮短檢測結果報告時間、最佳化檢查室效率並實現可擴展的檢測能力，使實驗室自動化成為現代醫療保健和生命科學基礎設施的重要組成部分。

實驗室自動化市場的最新市場動態和趨勢是什麼？

人才短缺和勞動力壓力正成為推動全球實驗室自動化市場成長的關鍵因素。至2026年，全球檢查室將面臨檢測量快速成長與熟練專業人員（包括臨床實驗室技術員、分子生物學家、臨床實驗室科學家和自動化專家）短缺之間的嚴峻挑戰。新冠疫情進一步加劇了這一局面，疫情一方面增加了對診斷檢測的需求，另一方面也引發了醫療系統內人員倦怠、提前退休和人才流失。羅氏診斷預測，到2030年，全球醫療保健產業可能面臨約1,100萬名醫護人員的缺口，其中檢查室專業人員將佔很大比例。

由於合格人員短缺，檢查室被迫從人工操作、任務導向型工作流程轉向自動化和數位化整合操作。自動化技術，例如自動化液體處理系統、機器人工作站、人工智慧驅動的工作流程軟體和全實驗室自動化 (TLA) 平台，使檢查室能夠在人員減少的情況下處理更多檢測項目，同時提高檢測結果的準確性、可重複性和報告速度。這些系統減少了對移液、檢體、貼標籤、離心、分液和資料輸入等重複性人工操作的依賴，使檢查室即使在長期人員短缺的情況下也能保持生產力。

推動自動化需求的主要因素之一是檢查室員工的世代交替。許多經驗豐富的實驗室專業人員即將退休，這引發了人們對機構特定專業知識和技術訣竅流失的擔憂。自動化將複雜的檢測流程標準化為可重複的數位化工作流程，確保營運的連續性，並最大限度地減少診斷和研究結果的差異。同時，檢查室也擴大利用自動化來緩解因重複性高容量檢測和人手不足導致的員工倦怠。

全球勞動力短缺危機正在改變檢查室的角色。檢查室專業人員正從重複性的手動操作轉向監督和分析職位，例如監督自動化流程、管理工作流程和解讀資料。現代自動化平台使一名技術人員監督以往需要多人才能完成的工作流程，從而顯著提高營運效率和檢測結果返回時間的可預測性。因此，大型企業正日益將自動化系統視為解決勞動力短缺和營運瓶頸的直接方案。

多項產業調查凸顯了人力資源挑戰的嚴峻程度，而這正是推動自動化普及的關鍵因素。西門子醫療和哈里斯·波爾的一項調查顯示，約39%的檢查室專業人員認為人員短缺是其檢查室面臨的最大營運挑戰，空缺率在7%至11%之間，在某些地區和專業領域甚至接近25%。此外，美國檢查室統計局預測，到2034年，醫療技術人員的年度職缺將達到約22,600個，進一步凸顯了日益嚴重的短缺問題。同樣，2025年MLO產業趨勢調查發現，近71%的檢查室專業人員將人員短缺視為主要營運問題，這促使他們加速投資於檢查室資訊學、工作流程最佳化軟體、機器人技術和人工智慧驅動的自動化工具。

總體而言，勞動力短缺和勞動力壓力預計將繼續成為全球檢查室自動化市場的長期結構性促進因素。隨著檢查室不斷面臨檢測複雜性增加、監管要求日益嚴格、患者數量不斷成長以及難以獲得熟練專業人員等挑戰，自動化技術將在提高擴充性、運營效率、品管和長期勞動力永續性方面發揮越來越重要的作用。因此，預計這些因素將在預測期內推動檢查室自動化市場的整體成長。

然而，高昂的實施成本、整合和技術複雜性，以及監管和安全方面的擔憂，共同構成了實驗室自動化普及和實施過程中的挑戰，阻礙了其市場成長。先進的自動化系統通常需要對機器人平台、軟體整合、基礎設施升級和維護進行大量前期投資，這使得中小型檢查室難以採用。此外，將自動化系統與現有實驗室工作流程、儀器和資料管理平台整合可能是一項技術複雜且耗時的任務。另外，關於資料完整性、病人安全和網路安全的嚴格監管要求也加重了檢查室的合規負擔，減緩了醫療保健和研究領域全面採用自動化解決方案的速度。

實驗室自動化市場區隔分析

實驗室自動化市場（按產品、自動化類型、工作流程、應用、最終用戶和地區分類）

實驗室自動化市場區域分析

北美實驗室自動化市場趨勢

預計到2025年，北美將佔據實驗室自動化市場41%的佔有率，成為所有地區中市場佔有率最大的地區。這主要得益於製藥和生物技術公司的強大實力、先進的醫療和研究基礎設施、不斷成長的檢測量以及數位化和人工智慧實驗室技術的快速普及。由於對高通量藥物研發、基因組研究、分子診斷和精準醫療應用的需求日益成長，該地區在全球實驗室自動化支出中佔據最大佔有率。此外，臨床和實驗室領域日益嚴重的勞動力短缺問題也加速了對自動化工作流程、機器人系統和實驗室資訊平台的投資，旨在提高營運效率並減少對人工操作的依賴。

美國是許多市場領導參與企業的所在地，包括賽默飛世爾科技（Thermo Fisher Scientific）、丹納赫公司（Danaher Corporation）、安捷倫科技（Agilent Technologies）、Revvity 和 Bio-Rad Laboratories，這些企業都在持續在美國市場部署下一代自動化平台，為其全球擴展做好準備。例如，Tecan Group 將於 2025 年推出 Veya™，這是一款專為可擴展的多組體學工作流程設計的自動化液體處理平台；而貝克曼庫爾特（Beckman Coulter）將推出用於基因組學和藥物發現應用的 Biomek i3 桌上型液體處理工作站。

此外，美國正在醫院檢查室、參考實驗室和製藥研發機構中快速採用全實驗室自動化（TLA）系統。西門子醫療和羅氏診斷等領先企業持續在美國部署整合式臨床實驗室自動化平台，以應對日益成長的診斷工作量和勞動力短缺問題。機器人技術、基於雲端的實驗室資訊學、人工智慧驅動的分析以及實驗室資訊管理系統（LIMS）的整合，進一步鞏固了美國在向智慧實驗室轉型方面的主導地位。

慢性病盛行率的上升和分子診斷技術的日益普及也是推動市場成長的因素。根據美國疾病管制與預防中心（CDC）統計，美國近90%的年度醫療保健支出用於慢性病治療，這顯著增加了對先進檢測和自動化技術的需求。此外，持續的勞動力短缺也是市場成長的主要催化劑，全美醫療技術人員的職缺率在7%到11%之間。美國勞工統計局預測，到2034年，醫療技術人員的年度職缺數量將達到約22,600個，這進一步凸顯了勞動力短缺問題的日益嚴峻。

總體而言，強大的研發投入、技術的早期應用、在基因組學和精準醫療領域不斷擴大的應用，以及領先的自動化公司的存在，使美國成為全球檢查室自動化的主要區域市場。

歐洲實驗室自動化市場趨勢

受製藥研發、臨床診斷、基因組學和精準醫療領域投資不斷成長，以及對高效標準化實驗室工作流程日益成長的需求的推動，歐洲實驗室自動化市場正經歷強勁且持續的成長。歐洲實驗室正迅速採用機器人系統、人工智慧驅動的自動化平台、自動化流體處理技術和基於雲端的實驗室管理系統，以提高生產力、減少人為錯誤並解決熟練實驗室專業人員短缺的問題。此外，政府對醫療現代化、生物製藥研發活動的拓展以及對高通量檢測的日益重視，進一步加速了德國、英國、法國和瑞士等國的市場擴張。近期調查顯示，高達28%的實驗室技術人員年齡超過55歲，在歐洲部分地區，醫院實驗室的職缺率甚至高達24%，給剩餘員工帶來了沉重的負擔。

此外，近期多項發展進一步加強了歐洲的檢查室自動化生態系統。 2025年1月，安捷倫科技與ABB機器人公司合作，共同開發先進的機器人檢查室自動化解決方案，旨在提升製藥和生物技術產業檢查室的速度、效率和工作流程整合。此外，歐洲檢查室正擴大採用人工智慧驅動的機器人「無軌自動化」系統，以最佳化檢體處理和檢查室物流。西門子醫療也在歐洲積極部署機器人檢查室工作流程解決方案，以實現檢體運輸、試劑提取和實驗室流程管理等任務的自動化。此外，憑藉其強大的製藥基礎設施、先進的研究生態系統和智慧檢查室技術的高普及率，德國繼續保持其作為該地區主要成長中心的地位。

亞太地區實驗室自動化市場趨勢

亞太地區正崛起為實驗室自動化市場的主要驅動力，這主要得益於中國、印度、日本、韓國和新加坡等國家製藥、生物技術和臨床診斷產業的快速發展。醫療保健領域的投資增加、生物製藥生產的活性化以及先進實驗室技術的日益普及，都顯著推動了該地區對自動化實驗室系統的需求。此外，慢性病和感染疾病的日益普及、基因組研究的拓展以及對精準醫療的日益重視，也促使實驗室採用高通量、人工智慧賦能的自動化平台，以提高效率和診斷準確性。亞太地區各國政府也透過資助舉措和科研基礎建設，支持醫療現代化和生命科學創新。此外，成本效益高的生產能力、CRO（合約研究組織）和 CDMO（合約開發和受託製造廠商）活動的擴展，以及全球製藥公司投資的增加，進一步推動了機器人液體處理系統、自動化分析儀和整合測試工作流程的採用，使亞太地區成為全球實驗室自動化市場成長最快的地區之一。

實驗室自動化市場的主要參與者有哪些？

以下是實驗室自動化市場的主要參與者。這些公司通常佔據最大的市場佔有率，並引領行業趨勢。

  • Thermo Fisher Scientific
  • Danaher Corporation
  • Siemens Healthineers
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies
  • PerkinElmer（Revvity）
  • Tecan Group
  • Hamilton Company
  • SPT Labtech
  • Hudson Lab Automation
  • Qiagen NV
  • 實驗室工作台，LabVantage Solutions
  • Biosero, Inc.
  • Opentrons
  • Scispot
  • Clinisys
  • Ginkgo Bioworks
  • LabWare
  • 其他

競爭格局如何影響實驗室自動化市場？

實驗室自動化市場的競爭格局高度分散，且高度依賴創新。全球領先企業透過先進的機器人技術、自動化流體處理系統、實驗室資訊學、人工智慧驅動的工作流程平台以及整合自動化解決方案展開競爭。賽默飛世爾科技、丹納赫公司、西門子醫療、安捷倫科技、Tecan集團和羅氏等主要企業正致力於拓展產品系列、增強研發能力並改善實驗室工作流程的整合，以保持其競爭優勢。此外，新興的自動化和軟體公司也加劇了競爭，它們提供靈活、模組化且經濟高效的實驗室解決方案。在對高通量檢測、精準醫療、基因組學和生物製藥研究日益成長的需求驅動下，各公司正增加對人工智慧、雲端連接、機器人自動化和數位化實驗室生態系統的投資。此外，策略合作夥伴關係、客製化自動化平台和可擴展的實驗室解決方案正成為供應商提高全球製藥、生物技術、臨床診斷和研究實驗室的效率、可重複性和營運擴充性的關鍵競爭策略。

實驗室自動化市場近期趨勢

  • 2025 年 1 月，安捷倫科技與 ABB 機器人公司合作，共同開發先進的機器人實驗室自動化解決方案，旨在提高製藥和生物技術領域實驗室的速度、效率和工作流程整合。

實驗室自動化市場的細分

  • 按服務產品分類的實驗室自動化市場
  • 產品
  • 自動液體處理系統
  • 機器人實驗室自動化系統
  • 檢測與分析自動化系統
  • 其他
  • 軟體
  • 實驗室資訊系統與軟體
  • 電子實驗室筆記本（ELN）
  • 科學資料管理系統（SDMS）
  • 其他
  • 服務
  • 按自動化類型分類的實驗室自動化
  • 任務導向的自動化（TTA）
  • 模組化自動化
  • 實驗室全面自動化（TLA）
  • 其他
  • 實驗室自動化工作流程分類
  • 樣品製備
  • 液體處理和分配
  • 樣品運輸和處理
  • 其他
  • 實驗室自動化應用實例
  • 藥物發現與開發
  • 臨床診斷
  • 基因組學和蛋白​​質組學
  • 細胞生物學和基於細胞的檢測
  • 其他
  • 接觸實驗室自動化最終用戶
  • 製藥和生物技術公司
  • 診斷檢查室
  • 學術和研究機構
  • CRO/CDMO
  • 實驗室自動化區域趨勢
  • 北美實驗室自動化市場
  • 美國實驗室自動化市場
  • 加拿大實驗室自動化市場
  • 墨西哥實驗室自動化市場
  • 歐洲實驗室自動化市場
  • 英國實驗室自動化市場
  • 德國實驗室自動化市場
  • 法國實驗室自動化市場
  • 義大利實驗室自動化市場
  • 西班牙實驗室自動化市場
  • 其他歐洲實驗室自動化市場
  • 亞太地區實驗室自動化市場
  • 中國實驗室自動化市場
  • 日本實驗室自動化市場
  • 印度實驗室自動化市場
  • 澳洲實驗室自動化市場
  • 韓國實驗室自動化市場
  • 亞太地區其他實驗室自動化市場
  • 其他區域實驗室自動化市場
  • 南美洲實驗室自動化市場
  • 中東實驗室自動化市場
  • 非洲實驗室自動化市場

影響分析

人工智慧驅動的創新與應用：

人工智慧驅動的創新正在變革實驗室自動化市場，使實驗室更加智慧、高效且數據驅動。人工智慧 (AI) 和機器學習技術正日益整合到自動化實驗室系統中，應用於預測分析、工作流程最佳化、自動資料解讀、異常檢測和即時決策等許多領域。在藥物發現和生物製藥研究領域，AI 驅動的自動化平台能夠更精準、更快速地分析大規模生物資料集，從而加速目標識別、化合物篩檢、檢測最佳化和先導化合物選擇。在臨床診斷和基因組學領域，AI 驅動的系統能夠改善檢體分類、影像分析、疾病檢測和診斷準確性，同時減少人為錯誤並縮短檢測結果的返回時間。 AI 也被應用於機器人流體處理系統、自主實驗室和智慧實驗室管理平台，以實現實驗設計的自動化、資源利用的最佳化以及實驗結果的可重複性。此外，整合 AI 的雲端實驗室資訊系統支援預測性維護、遠端監控和自動化工作流程協調，從而提升製藥、生物技術和臨床研究領域的實驗室生產力、擴充性和營運效率。

美國關稅政策對實驗室自動化市場的影響分析：

美國關稅政策對實驗室自動化市場的影響錯綜複雜，一方面推高了營運成本和供應鏈壓力，另一方面又促進了國內製造業發展和供應鏈多元化。許多實驗室自動化系統依賴從中國、日本和歐盟成員國等國家進口的電子元件、機器人硬體、半導體、感測器、實驗室設備和耗材。這些進口產品的關稅提高推高了實驗室自動化供應商的採購和製造成本，可能導致自動化設備、液體處理系統、分析儀器和實驗室軟體平台的價格上漲。

此外，關稅導致供應鏈中斷、前置作業時間延長，以及關鍵自動化組件採購的不確定性，使得實驗室和製造商更難維持穩定的採購週期和預算計畫。臨床和檢查室檢查室容易受到影響，因為對已驗證的設備或試劑的任何更改都需要額外的監管驗證和合規程序。

然而，關稅環境也促使企業加強國內製造能力，實現供應鏈本地化，並投資建設本地生產設施，以減少對進口的依賴。這種轉變可能為美國自動化設備製造商和供應商帶來長期成長機會。同時，檢查室也擴大採用人工智慧驅動的庫存管理、預測性採購工具和數位化供應鏈監控系統，以降低關稅相關風險並提高營運韌性。總而言之，儘管關稅可能會暫時增加成本並延緩採購決策，但它們也在加速美國實驗室自動化產業的策略重組和在地化進程。

這項分析能為客戶帶來哪些好處？

  • 成本管理：透過了解關稅趨勢，客戶可以預測成本上漲，並據此調整定價策略，以確保盈利。
  • 供應鏈最佳化：透過尋找替代來源並實現供應鏈多元化，客戶可以減少對高關稅地區的依賴，增強自身抵禦能力。
  • 監管合規：專家指導幫助客戶應對不斷變化的法規環境，從而保持合規並避免潛在的法律挑戰。
  • 策略規劃：深入了解關稅的影響，使客戶能夠就製造地、夥伴關係和打入市場策略做出明智的決策。

實驗室自動化市場報告要點

  • 對目前實驗室自動化市場規模（2025 年）的分析以及 8 年市場預測（2026 年至 2034 年）。
  • 過去三年發生的主要產品和技術開發、併購、夥伴關係和合資企業
  • 實驗室自動化市場領先的公司。
  • 實驗室自動化市場的其他競爭對手也面臨各種機會。
  • 哪些細分市場在 2025 年表現最佳？這些細分市場在 2034 年的表現又會如何？
  • 目前哪些地區、國家在實驗室自動化市場中表現最佳？
  • 企業應專注於哪些地區和國家，以尋求實驗室自動化市場的未來成長機會？

關於實驗室自動化市場的常見問題

1. 實驗室自動化市場的成長率是多少？

  • 預計從 2026 年到 2034 年的預測期內，實驗室自動化市場將以 10.07% 的年複合成長率成長。

2. 什麼是實驗室自動化市場？

  • 全球實驗室自動化市場預計將從 2025 年的 95.7112 億美元成長到 2034 年的 225.0113 億美元。

3. 哪個地區在實驗室自動化市場中佔據最大的市場佔有率？

  • 北美預計將成為實驗室自動化市場的主要驅動力，這得益於該地區眾多領先的製藥、生物技術和診斷公司，以及先進的醫療和研究基礎設施。該地區在藥物研發、臨床診斷和基因組學研究等領域，對機器人系統、人工智慧驅動的實驗室平台和數位化工作流程技術的應用日益廣泛。此外，生物製藥研發投入的增加、對高通量檢測需求的成長，以及賽默飛世爾科技、丹納赫公司和安捷倫科技等關鍵企業的存在，都進一步推動了該地區的市場成長。

4. 實驗室自動化市場的成長要素為何？

  • 人手不足和壓力、生物製藥研發的加速以及對高通量診斷日益成長的需求，都在推動實驗室自動化技術的快速普及，以彌補現代實驗室在處理能力和效率方面的不足。隨著熟練的實驗室人員日益稀缺，營運成本不斷上升，自動化有助於減少對人工操作的依賴，同時提高生產效率和一致性。同時，生物製藥研發管線的快速擴張和複雜的藥物發現過程需要更快的實驗速度、擴充性的篩檢和更高的數據準確性，而這些都可以透過自動化系統來實現。同樣，對高通量診斷檢測（尤其是在基因組學、感染疾病和個人化醫療領域）日益成長的需求，也進一步推動了對能夠快速、準確地處理大量檢體的自動化平台的需求，最終促進了整體市場的成長。

5. 實驗室自動化市場的主要企業有哪些？

  • 實驗室自動化市場的主要市場參與企業包括 Thermo Fisher Scientific、Danaher Corporation、Siemens Healthineers、Abbott、F. Hoffmann-La Roche Ltd、Agilent Technologies、PerkinElmer (Revvity)、Tecan Group、Hamilton Company、SPT Labtech、Hudson Lab Automation、Qiagen NVimable、Hamilton Company、Bench、Labtech、​​Moman Automation、Qiagen. Bioworks 和 LabWare。

目錄

第1章：實驗室自動化市場報告概述

第2章：實驗室自動化市場執行摘要

第3章：實驗室自動化市場關鍵因素分析

  • 實驗室自動化市場促進因素
    • 勞動力短缺和勞動力壓力
    • 加速生物製藥領域的研究與開發
    • 高通量診斷的需求
  • 實驗室自動化市場的限制與挑戰
    • 高經濟壁壘
    • 整合和技術複雜性
    • 監管和安全問題
  • 實驗室自動化市場的機遇
    • 人工智慧與機器人技術的融合

第4章：影響分析

  • 人工智慧驅動的創新和應用
  • 美國關稅影響分析

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：波特五力模型在實驗室自動化市場的應用分析

第7章：實驗室自動化市場評估

  • 透過提供
    • 產品
    • 軟體
    • 服務
  • 按自動化類型
    • 任務導向的自動化（TTA）
    • 模組化自動化
    • 綜合實驗室自動化（TLA）
    • 其他
  • 基於工作流程
    • 樣品製備
    • 液體的處理和分裝
    • 樣品運輸和處理
  • 透過使用
    • 藥物發現與開發
    • 臨床診斷
    • 基因組學和蛋白​​質組學
    • 細胞生物學和基於細胞的檢測
  • 最終用戶
    • 製藥和生物技術公司
    • 診斷檢查室
    • 學術和研究機構
    • CRO/CDMO
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 競爭情勢

第9章：創業資金籌措與投資趨勢

第10章：實驗室自動化市場中的公司與產品概況

  • Thermo Fisher Scientific
  • Danaher Corporation
  • Siemens Healthineers
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies
  • PerkinElmer（Revvity）
  • Tecan Group
  • Hamilton Company
  • SPT Labtech
  • Hudson Lab Automation
  • Qiagen NV
  • Benchling
  • LabVantage Solutions
  • Biosero
  • Opentrons
  • Scispot
  • Clinisys
  • Ginkgo Bioworks
  • LabWare

第11章：KOL的觀點

第12章 專案方法

第13章：關於 DelveInsight

第14章 免責聲明與聯絡方式

Product Code: DIMDCL0792

Lab Automation Market Summary

  • The global lab automation market is expected to increase from USD 9,571.12 million in 2025 to USD 22,501.13 million by 2034, reflecting strong and sustained growth.
  • The global lab automation market is growing at a CAGR of 10.07% during the forecast period from 2026 to 2034.
  • Labor shortages and workforce pressure, accelerated biopharmaceutical R&D, and rising demand for high-throughput diagnostics are collectively accelerating the adoption of lab automation by addressing both capacity and efficiency gaps in modern laboratories. As skilled laboratory personnel become increasingly limited and operational costs rise, automation helps reduce dependency on manual workflows while improving productivity and consistency. At the same time, rapid expansion in biopharma pipelines and complex drug discovery processes requires faster experimentation, scalable screening, and higher data accuracy, which automated systems can deliver. Similarly, the growing need for high-throughput diagnostic testing, especially in genomics, infectious disease, and personalized medicine, further drives demand for automated platforms capable of processing large sample volumes with speed and precision, ultimately strengthening overall market growth.
  • The leading companies operating in the lab automation market include Thermo Fisher Scientific, Danaher Corporation, Siemens Healthineers, Abbott, F. Hoffmann-La Roche Ltd, Agilent Technologies, PerkinElmer (Revvity), Tecan Group, Hamilton Company, SPT Labtech, Hudson Lab Automation, Qiagen N.V., Benchling, LabVantage Solutions, Biosero, Inc., Opentrons, Scispot, Clinisys, Ginkgo Bioworks, LabWare, and others.
  • North America is expected to dominate the lab automation market due to the strong presence of major pharmaceutical, biotechnology, and diagnostic companies, along with advanced healthcare and research infrastructure. The region has high adoption of robotic systems, AI-enabled laboratory platforms, and digital workflow technologies across drug discovery, clinical diagnostics, and genomics research. In addition, increasing investments in biopharmaceutical R&D, growing demand for high-throughput testing, and the presence of leading market players such as Thermo Fisher Scientific, Danaher Corporation, and Agilent Technologies are further supporting regional market growth.
  • In the offering segment of the lab automation market, the product category is estimated to account for the largest market share in 2025.

Factors Contributing to the Growth of the Lab Automation Market

  • Labor shortages & workforce pressure leading to a surge in lab automation: The growing shortage of skilled laboratory professionals and increasing workforce costs are significantly boosting the demand for lab automation. Automated systems help laboratories reduce manual workloads, improve operational efficiency, minimize human errors, and maintain consistent productivity even with limited staff availability.
  • Accelerated R&D in biopharmaceuticals: Rapid growth in biopharmaceutical research and drug development is increasing the need for automated laboratory workflows. Lab automation enables faster sample processing, high-throughput screening, and improved data accuracy, helping pharmaceutical and biotechnology companies accelerate drug discovery and development timelines.
  • Demand for high-throughput diagnostics: The rising need for large-scale diagnostic testing in areas such as genomics, infectious diseases, and personalized medicine is driving adoption of lab automation systems. Automated diagnostic platforms can process high sample volumes quickly and accurately, improving turnaround times and supporting efficient clinical laboratory operations.

Lab Automation Market Report Segmentation

This lab automation market report offers a comprehensive overview of the global lab automation market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Offering (Product {Automated Liquid Handling Systems, Robotic Laboratory Automation Systems, Detection & Analytical Automation Systems, and Others}, Software {Laboratory Informatics & Software, Electronic Lab Notebooks (ELN), Scientific Data Management Systems (SDMS), and Others} and Services), Automation Type (Task-targeted Automation (TTA, Modular Automation), Total Laboratory Automation (TLA), and Others), Workflow (Sample Preparation, Liquid Handling & Dispensing, Sample Transport & handling, and Others), Application (Drug Discovery & Development, Clinical Diagnostics, Genomics & Proteomics, Cell Biology & Cell-based Assays, and Others), End-Users (Pharma & biotech companies, Diagnostic labs, Academic & Research Institutes, and CRO/CDMOs), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing lab automation market.

The lab automation market refers to the comprehensive ecosystem of automated hardware, specialized software, and integrated robotic platforms designed to perform laboratory tasks with minimal human intervention, thereby enhancing throughput, precision, and data integrity across clinical diagnostics and research workflows.

Labor shortages and workforce pressure, accelerated biopharmaceutical R&D, and rising demand for high-throughput diagnostics are collectively driving strong growth in the lab automation market by helping laboratories overcome operational, efficiency, and scalability challenges. As the availability of skilled laboratory professionals continues to decline in many regions, laboratories are increasingly adopting automation solutions to reduce reliance on manual processes, improve workflow consistency, minimize human error, and maintain productivity despite staffing constraints. Automated liquid handling systems, robotic sample processors, and AI-enabled workflow platforms allow laboratories to perform repetitive and complex tasks with greater speed and accuracy.

At the same time, the rapid expansion of biopharmaceutical research, including biologics, cell and gene therapies, vaccines, and personalized medicines, is creating a growing need for faster and more efficient research workflows. Pharmaceutical and biotechnology companies are investing heavily in automated laboratory technologies to accelerate drug discovery, high-throughput screening, sample preparation, and data analysis. Automation not only shortens R&D timelines but also improves reproducibility and supports large-scale experimentation required for modern drug development.

In addition, the increasing demand for high-throughput diagnostics is further boosting the adoption of lab automation systems across clinical and diagnostic laboratories. Rising testing volumes in genomics, infectious disease detection, molecular diagnostics, and precision medicine require laboratories to process thousands of samples rapidly while maintaining high accuracy and regulatory compliance. Automated diagnostic platforms help improve turnaround times, optimize laboratory efficiency, and enable scalable testing capabilities, making lab automation an essential component of modern healthcare and life sciences infrastructure.

What are the latest Lab Automation market dynamics and trends?

Labor shortages and workforce pressure have emerged as one of the primary drivers accelerating growth in the global Laboratory Automation market. In 2026, laboratories worldwide are facing a significant imbalance between rapidly rising testing volumes and the declining availability of skilled professionals, including medical laboratory technologists, molecular biologists, clinical laboratory scientists, and automation specialists. The situation has intensified following the COVID-19 pandemic, which increased diagnostic testing demand while simultaneously contributing to burnout, early retirements, and workforce attrition across healthcare systems. According to workforce projections discussed by Roche Diagnostics, the global healthcare sector could face a shortage of nearly 11 million healthcare workers by 2030, with laboratory professionals representing a critical portion of this gap.

The shortage of qualified personnel is forcing laboratories to shift from manual and task-oriented workflows toward automated and digitally integrated operations. Automation technologies such as automated liquid handling systems, robotic workstations, AI-enabled workflow software, and Total Laboratory Automation (TLA) platforms enable laboratories to process significantly higher test volumes with fewer personnel while improving accuracy, reproducibility, and turnaround times. These systems reduce dependence on repetitive manual activities such as pipetting, sample sorting, labeling, centrifugation, aliquoting, and data entry, allowing laboratories to sustain productivity despite chronic understaffing.

A major factor strengthening automation demand is the ongoing generational turnover within the laboratory workforce. A large proportion of experienced laboratory professionals are approaching retirement age, creating concerns around the loss of specialized institutional knowledge and technical expertise. Automation helps standardize complex laboratory procedures into reproducible digital workflows, ensuring operational continuity and minimizing variability in diagnostic and research outputs. At the same time, laboratories are increasingly using automation to reduce employee burnout associated with repetitive high-volume testing and staff shortages.

The workforce crisis is also reshaping laboratory roles globally. Instead of performing repetitive manual tasks, laboratory professionals are increasingly transitioning toward supervisory and analytical responsibilities, including automation oversight, workflow management, and data interpretation. Modern automation platforms allow a single technician to oversee workflows that previously required multiple personnel, significantly improving operational efficiency and turnaround time predictability. As a result, major companies are increasingly positioning automation systems as direct solutions to labor shortages and operational bottlenecks.

Several industry surveys highlight the scale of workforce-related challenges driving automation adoption. According to a survey conducted by Siemens Healthineers and the Harris Poll, approximately 39% of laboratory professionals identified limited staffing as the biggest operational challenge facing laboratories, while laboratory vacancy rates range between 7% and 11%, reaching nearly 25% in certain regions and specialties. In addition, the U.S. Bureau of Labor Statistics projects approximately 22,600 annual openings for medical laboratory technologists through 2034, further highlighting the widening workforce gap. Similarly, the 2025 MLO State of the Industry Survey found that nearly 71% of laboratory professionals consider staffing shortages a major operational concern, accelerating investment in laboratory informatics, workflow optimization software, robotics, and AI-driven automation tools.

Overall, labor shortages and workforce pressure are expected to remain long-term structural drivers for the global laboratory automation market. As laboratories continue to face increasing test complexity, higher regulatory requirements, growing patient volumes, and limited access to skilled professionals, automation technologies will play an increasingly critical role in improving scalability, operational efficiency, quality control, and long-term workforce sustainability. Thus, the factors mentioned above are expected to boost the overall market of lab automation during the forecast period.

However, the high financial barriers, integration and technical complexity, and regulatory and security concerns are collectively limiting the growth of the lab automation market by creating challenges in adoption and implementation. Advanced automation systems often require significant initial investments in robotic platforms, software integration, infrastructure upgrades, and maintenance, making them difficult for small and mid-sized laboratories to afford. In addition, integrating automated systems with existing laboratory workflows, instruments, and data management platforms can be technically complex and time-consuming. Furthermore, strict regulatory requirements related to data integrity, patient safety, and cybersecurity increase compliance burdens for laboratories, slowing the adoption of fully automated solutions across healthcare and research environments.

Lab Automation Market Segment Analysis

Lab Automation Market by Offering (Product {Automated Liquid Handling Systems, Robotic Laboratory Automation Systems, Detection & Analytical Automation Systems, and Others}, Software {Laboratory Informatics & Software, Electronic Lab Notebooks (ELN), Scientific Data Management Systems (SDMS), and Others} and Services), Automation Type (Task-targeted Automation (TTA, Modular Automation), Total Laboratory Automation (TLA), and Others), Workflow (Sample Preparation, Liquid Handling & Dispensing, Sample Transport & handling, and Others), Application (Drug Discovery & Development, Clinical Diagnostics, Genomics & Proteomics, Cell Biology & Cell-based Assays, and Others), End-Users (Pharma & biotech companies, Diagnostic labs, Academic & Research Institutes, and CRO/CDMOs), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Lab Automation Market Regional Analysis

North America Lab Automation Market Trends

North America is expected to account for the highest proportion of 41% of the lab automation market in 2025, out of all regions, driven by the strong presence of pharmaceutical and biotechnology companies, advanced healthcare and research infrastructure, rising laboratory testing volumes, and rapid adoption of digital and AI-enabled laboratory technologies. The country accounts for the largest share of global laboratory automation spending due to increasing demand for high-throughput drug discovery, genomics research, molecular diagnostics, and precision medicine applications. In addition, growing workforce shortages across clinical and research laboratories are accelerating investments in automated workflows, robotic systems, and laboratory informatics platforms to improve operational efficiency and reduce dependence on manual processes.

The country is home to several major market players, including Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, Revvity, and Bio-Rad Laboratories, all of which continue to launch next-generation automation platforms in the U.S. market before broader global expansion. For instance, in 2025, Tecan Group launched its Veya(TM) automated liquid handling platform designed for scalable multi-omics workflows, while Beckman Coulter introduced the Biomek i3 Benchtop Liquid Handler for genomics and drug discovery applications.

The country is also witnessing the rapid adoption of Total Laboratory Automation (TLA) systems across hospital laboratories, reference laboratories, and pharmaceutical research facilities. Major players such as Siemens Healthineers and Roche Diagnostics continue to expand integrated clinical laboratory automation platforms in the U.S. to address growing diagnostic workloads and workforce shortages. Increasing integration of robotics, cloud-based laboratory informatics, AI-driven analytics, and Laboratory Information Management Systems (LIMS) is further strengthening the country's leadership position in smart laboratory transformation.

The increasing prevalence of chronic diseases and rising adoption of molecular diagnostics are further supporting market growth. According to the Centers for Disease Control and Prevention (CDC), chronic diseases account for nearly 90% of annual healthcare expenditures in the U.S., significantly increasing demand for advanced laboratory testing and automation. Additionally, ongoing workforce shortages remain a major growth catalyst, with laboratory vacancy rates ranging between 7% and 11% across the country. In addition, the U.S. Bureau of Labor Statistics projected approximately 22,600 annual openings for medical laboratory technologists through 2034, further highlighting the widening workforce gap.

Collectively, strong R&D investments, early technology adoption, expanding genomics and precision medicine applications, and the presence of leading automation companies position the U.S. as the dominant regional market for laboratory automation globally.

Europe Lab Automation Market Trend

The lab automation market in Europe is witnessing strong and sustained growth due to increasing investments in pharmaceutical research, clinical diagnostics, genomics, and precision medicine, along with rising demand for efficient and standardized laboratory workflows. European laboratories are rapidly adopting robotic systems, AI-enabled automation platforms, automated liquid handling technologies, and cloud-based laboratory management systems to improve productivity, reduce human error, and address shortages of skilled laboratory professionals. In addition, supportive government initiatives for healthcare modernization, growing biopharmaceutical R&D activities, and increasing focus on high-throughput testing are further accelerating market expansion across countries such as Germany, the United Kingdom, France, and Switzerland. According to recent studies, up to 28% of lab technicians were over 55, and some regions in Europe reported as much as a 24% vacancy rate in hospital laboratories, placing extreme pressure on remaining staff.

Additionally, several recent developments are further strengthening the European lab automation ecosystem. In January 2025, Agilent Technologies partnered with ABB Robotics to co-develop advanced robotic laboratory automation solutions aimed at improving laboratory speed, efficiency, and workflow integration across pharmaceutical and biotechnology applications. Additionally, European laboratories are increasingly integrating AI-driven and robotics-enabled "trackless automation" systems to enhance sample handling and laboratory logistics. Siemens Healthineers has also been actively expanding robotic laboratory workflow solutions across Europe to automate tasks such as sample transport, reagent retrieval, and laboratory process management. Furthermore, Germany continues to remain a major regional growth hub due to its strong pharmaceutical infrastructure, advanced research ecosystem, and high adoption of smart laboratory technologies.

Asia-Pacific Lab Automation Market Trends

The Asia Pacific (APAC) region is emerging as a major growth driver for the lab automation market due to the rapid expansion of the pharmaceutical, biotechnology, and clinical diagnostics industries across countries such as China, India, Japan, South Korea, and Singapore. Increasing healthcare investments, growing biopharmaceutical manufacturing activities, and rising adoption of advanced laboratory technologies are significantly accelerating demand for automated laboratory systems in the region. In addition, the increasing prevalence of chronic and infectious diseases, expanding genomics research, and rising focus on precision medicine are encouraging laboratories to adopt high-throughput and AI-enabled automation platforms to improve efficiency and diagnostic accuracy. Governments across APAC are also supporting healthcare modernization and life sciences innovation through funding initiatives and research infrastructure development. Furthermore, the presence of cost-effective manufacturing capabilities, expanding CRO and CDMO activities, and growing investments by global pharmaceutical companies are further strengthening the adoption of robotic liquid handling systems, automated analyzers, and integrated laboratory workflows, making APAC one of the fastest-growing regions in the global lab automation market.

Who are the major players in the lab automation market?

The following are the leading companies in the lab automation market. These companies collectively hold the largest market share and dictate industry trends.

  • Thermo Fisher Scientific
  • Danaher Corporation
  • Siemens Healthineers
  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • Agilent Technologies
  • PerkinElmer (Revvity)
  • Tecan Group
  • Hamilton Company
  • SPT Labtech
  • Hudson Lab Automation
  • Qiagen N.V.
  • Benchling, LabVantage Solutions
  • Biosero, Inc.
  • Opentrons
  • Scispot
  • Clinisys
  • Ginkgo Bioworks
  • LabWare
  • Others

How is the competitive landscape shaping the lab automation market?

The competitive landscape of the lab automation market is highly fragmented and innovation-focused, with major global companies competing through advanced robotics, automated liquid handling systems, laboratory informatics, AI-enabled workflow platforms, and integrated automation solutions. Leading players such as Thermo Fisher Scientific, Danaher Corporation, Siemens Healthineers, Agilent Technologies, Tecan Group, and F. Hoffmann-La Roche Ltd. are focusing on expanding their product portfolios, strengthening R&D capabilities, and improving laboratory workflow integration to maintain market competitiveness. The market is also witnessing growing competition from emerging automation and software-focused companies offering flexible, modular, and cost-effective laboratory solutions. Increasing demand for high-throughput testing, precision medicine, genomics, and biopharmaceutical research is encouraging companies to invest in AI, cloud connectivity, robotic automation, and digital laboratory ecosystems. In addition, strategic collaborations, customized automation platforms, and scalable laboratory solutions are becoming key competitive strategies as vendors aim to improve laboratory efficiency, reproducibility, and operational scalability across pharmaceutical, biotechnology, clinical diagnostics, and research laboratories worldwide.

Recent Developmental Activities in the Lab Automation Market

  • In January 2025, Agilent Technologies partnered with ABB Robotics to co-develop advanced robotic laboratory automation solutions aimed at improving laboratory speed, efficiency, and workflow integration across pharmaceutical and biotechnology applications.

Lab Automation Market Segmentation

  • Lab Automation by Offering Exposure
  • Product
  • Automated Liquid Handling Systems
  • Robotic Laboratory Automation Systems
  • Detection & Analytical Automation Systems
  • Others
  • Software
  • Laboratory Informatics & Software
  • Electronic Lab Notebooks (ELN)
  • Scientific Data Management Systems (SDMS)
  • Others
  • Services
  • Lab Automation by Automation Type Exposure
  • Task-targeted Automation (TTA)
  • Modular Automation
  • Total Laboratory Automation (TLA)
  • Others
  • Lab Automation Workflow Exposure
  • Sample Preparation
  • Liquid Handling & Dispensing
  • Sample Transport & Handling
  • Others
  • Lab Automation Application Exposure
  • Drug Discovery & Development
  • Clinical Diagnostics
  • Genomics & Proteomics
  • Cell Biology & Cell-based Assays
  • Others
  • Lab Automation End-Users Exposure
  • Pharma & biotech Companies
  • Diagnostic labs
  • Academic & Research Institutes
  • CRO/CDMOs
  • Lab Automation Geography Exposure
  • North America Lab Automation Market
  • United States Lab Automation Market
  • Canada Lab Automation Market
  • Mexico Lab Automation Market
  • Europe Lab Automation Market
  • United Kingdom Lab Automation Market
  • Germany Lab Automation Market
  • France Lab Automation Market
  • Italy Lab Automation Market
  • Spain Lab Automation Market
  • Rest of Europe Lab Automation Market
  • Asia-Pacific Lab Automation Market
  • China Lab Automation Market
  • Japan Lab Automation Market
  • India Lab Automation Market
  • Australia Lab Automation Market
  • South Korea Lab Automation Market
  • Rest of Asia-Pacific Lab Automation Market
  • Rest of the World Lab Automation Market
  • South America Lab Automation Market
  • Middle East Lab Automation Market
  • Africa Lab Automation Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations are transforming the lab automation market by enabling laboratories to become more intelligent, efficient, and data-driven. Artificial intelligence and machine learning technologies are increasingly being integrated into automated laboratory systems for applications such as predictive analytics, workflow optimization, automated data interpretation, anomaly detection, and real-time decision-making. In drug discovery and biopharmaceutical research, AI-powered automation platforms help accelerate target identification, compound screening, assay optimization, and lead candidate selection by rapidly analyzing large biological datasets with greater accuracy. In clinical diagnostics and genomics, AI-enabled systems improve sample classification, image analysis, disease detection, and diagnostic accuracy while reducing manual errors and turnaround times. AI is also being used in robotic liquid handling systems, self-driving laboratories, and smart laboratory management platforms to automate experimental design, optimize resource utilization, and improve reproducibility. Additionally, AI-integrated cloud-based laboratory informatics systems support predictive maintenance, remote monitoring, and automated workflow coordination, helping laboratories enhance productivity, scalability, and operational efficiency across pharmaceutical, biotechnology, and clinical research environments.

U.S. Tariff Impact Analysis on Lab Automation Market:

U.S. tariff policies are creating a mixed impact on the lab automation market by increasing operational costs and supply chain pressures while also encouraging domestic manufacturing and supply chain diversification. Many lab automation systems depend on imported electronic components, robotics hardware, semiconductors, sensors, laboratory instruments, and consumables sourced from countries such as China, Japan, and members of the European Union. Rising tariffs on these imported products are increasing procurement and manufacturing costs for laboratory automation vendors, which can lead to higher prices for automated instruments, liquid handling systems, analyzers, and laboratory software platforms.

In addition, tariffs are contributing to supply chain disruptions, longer lead times, and uncertainty in sourcing critical automation components, making it more difficult for laboratories and manufacturers to maintain stable procurement cycles and budget planning. Clinical and diagnostic laboratories are particularly vulnerable because changes in validated instruments or reagents often require additional regulatory validation and compliance procedures.

However, the tariff environment is also encouraging companies to strengthen domestic manufacturing capabilities, regionalize supply chains, and invest in local production facilities to reduce dependence on imports. This shift may support long-term growth opportunities for U.S.-based automation manufacturers and suppliers. At the same time, laboratories are increasingly adopting AI-driven inventory management, predictive procurement tools, and digital supply chain monitoring systems to mitigate tariff-related risks and improve operational resilience. Overall, while tariffs may temporarily increase costs and slow purchasing decisions, they are also accelerating strategic restructuring and localization efforts within the U.S. lab automation industry.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the lab automation market report study

  • Market size analysis for the current lab automation market size (2025), and market forecast for 8 years (2026 to 2034)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the lab automation market.
  • Various opportunities available for the other competitors in the lab automation market space.
  • What are the top-performing segments in 2025? How these segments will perform in 2034?
  • Which are the top-performing regions and countries in the current lab automation market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the lab automation market growth in the future.

Frequently Asked Questions for the Lab Automation Market

1. What is the growth rate of the lab automation market?

  • The lab automation market is estimated to grow at a CAGR of 10.07% during the forecast period from 2026 to 2034.

2. What is the market for lab automation?

  • The global lab automation market is expected to increase from USD 9,571.12 million in 2025 to USD 22,501.13 million by 2034.

3. Which region has the highest share in the lab automation market?

  • North America is expected to dominate the lab automation market due to the strong presence of major pharmaceutical, biotechnology, and diagnostic companies, along with advanced healthcare and research infrastructure. The region has high adoption of robotic systems, AI-enabled laboratory platforms, and digital workflow technologies across drug discovery, clinical diagnostics, and genomics research. In addition, increasing investments in biopharmaceutical R&D, growing demand for high-throughput testing, and the presence of leading market players such as Thermo Fisher Scientific, Danaher Corporation, and Agilent Technologies are further supporting regional market growth.

4. What are the drivers for the lab automation market?

  • Labor shortages and workforce pressure, accelerated biopharmaceutical R&D, and rising demand for high-throughput diagnostics are collectively accelerating the adoption of lab automation by addressing both capacity and efficiency gaps in modern laboratories. As skilled laboratory personnel become increasingly limited and operational costs rise, automation helps reduce dependency on manual workflows while improving productivity and consistency. At the same time, rapid expansion in biopharma pipelines and complex drug discovery processes requires faster experimentation, scalable screening, and higher data accuracy, which automated systems can deliver. Similarly, the growing need for high-throughput diagnostic testing, especially in genomics, infectious disease, and personalized medicine, further drives demand for automated platforms capable of processing large sample volumes with speed and precision, ultimately strengthening overall market growth.

5. Who are the key players operating in the lab automation market?

  • Some of the key market players operating in the lab automation market include Thermo Fisher Scientific, Danaher Corporation, Siemens Healthineers, Abbott, F. Hoffmann-La Roche Ltd, Agilent Technologies, PerkinElmer (Revvity), Tecan Group, Hamilton Company, SPT Labtech, Hudson Lab Automation, Qiagen N.V., Benchling, LabVantage Solutions, Biosero, Inc., Opentrons, Scispot, Clinisys, Ginkgo Bioworks, LabWare, and others.

Table of Contents

1. Lab Automation Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Lab Automation Market Executive Summary

  • 2.1 Market at Glance

3. Lab Automation Market Key Factors Analysis

  • 3.1 Lab Automation Market Drivers
    • 3.1.1 Labor shortages & workforce pressure
    • 3.1.2 Accelerated R&D in biopharmaceuticals
    • 3.1.3 Demand for high-throughput diagnostics
  • 3.2 Lab Automation Market Restraints and Challenges
    • 3.2.1 High financial barriers
    • 3.2.2 Integration and technical complexity
    • 3.2.3 Regulatory and security concerns
  • 3.3 Lab Automation Market Opportunity
    • 3.3.1 Integration of artificial intelligence and robotics

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Lab Automation Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Lab Automation Market Assessment

  • 7.1 By Offering
    • 7.1.1 Product
      • 7.1.1.1 Automated Liquid Handling Systems
      • 7.1.1.2 Robotic Laboratory Automation Systems
      • 7.1.1.3 Detection & Analytical Automation Systems
      • 7.1.1.4 Others
    • 7.1.2 Software
      • 7.1.2.1 Laboratory Informatics & Software
      • 7.1.2.2 Electronic Lab Notebooks (ELN)
      • 7.1.2.3 Scientific Data Management Systems (SDMS)
      • 7.1.2.4 Others
    • 7.1.3 Services
  • 7.2 By Automation Type
    • 7.2.1 Task-targeted Automation (TTA)
    • 7.2.2 Modular Automation
    • 7.2.3 Total Laboratory Automation (TLA)
    • 7.2.4 Others
  • 7.3 By Workflow
    • 7.3.1 Sample Preparation
    • 7.3.2 Liquid Handling & Dispensing
    • 7.3.3 Sample Transport & Handling
    • 7.3.4 Others
  • 7.4 By Application
    • 7.4.1 Drug Discovery & Development
    • 7.4.2 Clinical Diagnostics
    • 7.4.3 Genomics & Proteomics
    • 7.4.4 Cell Biology & Cell-based Assays
    • 7.4.5 Others
  • 7.5 By End-Users
    • 7.5.1 Pharma & biotech companies
    • 7.5.2 Diagnostic labs
    • 7.5.3 Academic & Research Institutes
    • 7.5.4 CRO/CDMOs
  • 7.6 By Geography
    • 7.6.1 North America
      • 7.6.1.1 United States Lab Automation Market Size in USD million (2023-2034)
      • 7.6.1.2 Canada Lab Automation Market Size in USD million (2023-2034)
      • 7.6.1.3 Mexico Lab Automation Market Size in USD million (2023-2034)
    • 7.6.2 Europe
      • 7.6.2.1 France Lab Automation Market Size in USD million (2023-2034)
      • 7.6.2.2 Germany Lab Automation Market Size in USD million (2023-2034)
      • 7.6.2.3 United Kingdom Lab Automation Market Size in USD million (2023-2034)
      • 7.6.2.4 Italy Lab Automation Market Size in USD million (2023-2034)
      • 7.6.2.5 Spain Lab Automation Market Size in USD million (2023-2034)
      • 7.6.2.6 Rest of Europe Lab Automation Market Size in USD million (2023-2034)
    • 7.6.3 Asia-Pacific
      • 7.6.3.1 China Lab Automation Market Size in USD million (2023-2034)
      • 7.6.3.2 Japan Lab Automation Market Size in USD million (2023-2034)
      • 7.6.3.3 India Lab Automation Market Size in USD million (2023-2034)
      • 7.6.3.4 Australia Lab Automation Market Size in USD million (2023-2034)
      • 7.6.3.5 South Korea Lab Automation Market Size in USD million (2023-2034)
      • 7.6.3.6 Rest of Asia-Pacific Lab Automation Market Size in USD million (2023-2034)
    • 7.6.4 Rest of the World (RoW)
      • 7.6.4.1 Middle East Lab Automation Market Size in USD million (2023-2034)
      • 7.6.4.2 Africa Lab Automation Market Size in USD million (2023-2034)
      • 7.6.4.3 South America Lab Automation Market Size In USD Million (2023-2034)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Lab Automation Market Company and Product Profiles

  • 10.1 Thermo Fisher Scientific
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 Danaher Corporation
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Siemens Healthineers
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Abbott
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 F. Hoffmann-La Roche Ltd.
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Agilent Technologies
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 PerkinElmer (Revvity)
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Tecan Group
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Hamilton Company
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 SPT Labtech
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 Hudson Lab Automation
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 Qiagen N.V.
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 Benchling
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 LabVantage Solutions
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 Biosero, Inc.
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 Opentrons
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 Scispot
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Clinisys
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Ginkgo Bioworks
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 LabWare
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1 Lab Automation Market in Global (2023-2034)
  • Table 2 Lab Automation Market in Global by Offering (2023-2034)
  • Table 3 Lab Automation Market in Global by Automation Type (2023-2034)
  • Table 4 Lab Automation Market in Global by Workflow (2023-2034)
  • Table 5 Lab Automation Market in Global by Application (2023-2034)
  • Table 6 Lab Automation Market in Global by End-Users (2023-2034)
  • Table 7 Lab Automation Market in Global by Geography (2023-2034)
  • Table 8 Lab Automation Market in North America (2023-2034)
  • Table 9 Lab Automation Market in the United States (2023-2034)
  • Table 10 Lab Automation Market in Canada (2023-2034)
  • Table 11 Lab Automation Market in Mexico (2023-2034)
  • Table 12 Lab Automation Market in Europe (2023-2034)
  • Table 13 Lab Automation Market in France (2023-2034)
  • Table 14 Lab Automation Market in Germany (2023-2034)
  • Table 15 Lab Automation Market in United Kingdom (2023-2034)
  • Table 16 Lab Automation Market in Italy (2023-2034)
  • Table 17 Lab Automation Market in Spain (2023-2034)
  • Table 18 Lab Automation Market in the Rest of Europe (2023-2034)
  • Table 19 Lab Automation Market in Asia-Pacific (2023-2034)
  • Table 20 Lab Automation Market in China (2023-2034)
  • Table 21 Lab Automation Market in Japan (2023-2034)
  • Table 22 Lab Automation Market in India (2023-2034)
  • Table 23 Lab Automation Market in Australia (2023-2034)
  • Table 24 Lab Automation Market in South Korea (2023-2034)
  • Table 25 Lab Automation Market in Rest of Asia-Pacific (2023-2034)
  • Table 26 Lab Automation Market in the Rest of the World (2023-2034)
  • Table 27 Lab Automation Market in the Middle East (2023-2034)
  • Table 28 Lab Automation Market in Africa (2023-2034)
  • Table 29 Lab Automation Market in South America (2023-2034)
  • Table 30 Competitive Landscape
  • Table 31 Startup Funding & Investment Trends

List of Figures

  • Figure 1: Lab Automation Market Drivers
  • Figure 2: Lab Automation Market Restraints
  • Figure 3: Lab Automation Market Opportunities
  • Figure 4: AI-Powered Innovations in Lab Automation Market
  • Figure 5: US Tariff Impact on Lab Automation Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Lab Automation Market in Global (2023-2034)
  • Figure 10: Lab Automation Market in Global by Offering (2023-2034)
  • Figure 11: Lab Automation Market in Global by Automation Type (2023-2034)
  • Figure 12: Lab Automation Market in Global by Workflow (2023-2034)
  • Figure 13: Lab Automation Market in Global by Application (2023-2034)
  • Figure 14: Lab Automation Market in Global by End-Users (2023-2034)
  • Figure 15: Lab Automation Market in Global by Geography (2023-2034)
  • Figure 16: Lab Automation Market in North America (2023-2034)
  • Figure 17: Lab Automation Market in the United States (2023-2034)
  • Figure 18: Lab Automation Market in Canada (2023-2034)
  • Figure 19: Lab Automation Market in Mexico (2023-2034)
  • Figure 20: Lab Automation Market in Europe (2023-2034)
  • Figure 21: Lab Automation Market in France (2023-2034)
  • Figure 22: Lab Automation Market in Germany (2023-2034)
  • Figure 23: Lab Automation Market in United Kingdom (2023-2034)
  • Figure 24: Lab Automation Market in Italy (2023-2034)
  • Figure 25: Lab Automation Market in Spain (2023-2034)
  • Figure 26: Lab Automation Market in the Rest of Europe (2023-2034)
  • Figure 27: Lab Automation Market in Asia-Pacific (2023-2034)
  • Figure 28: Lab Automation Market in China (2023-2034)
  • Figure 29: Lab Automation Market in Japan (2023-2034)
  • Figure 30: Lab Automation Market in India (2023-2034)
  • Figure 31: Lab Automation Market in Australia (2023-2034)
  • Figure 32: Lab Automation Market in South Korea (2023-2034)
  • Figure 33: Lab Automation Market in Rest of Asia-Pacific (2023-2034)
  • Figure 34: Lab Automation Market in the Rest of the World (2023-2034)
  • Figure 35: Lab Automation Market in the Middle East (2023-2034)
  • Figure 36: Lab Automation Market in Africa (2023-2034)
  • Figure 37: Lab Automation Market in South America (2023-2034)
  • Figure 38: Competitive Landscape
  • Figure 39: Startup Funding & Investment Trends